|
Name |
(5R,7S)-5,7-dihydroxy-2-[(E)-prop-1-en-1-yl]-5,6,7,8-tetrahydro-4H-chromen-4-one
|
Molecular Formula | C12H14O4 | |
IUPAC Name* |
(5R,7S)-5,7-dihydroxy-2-[(E)-prop-1-enyl]-5,6,7,8-tetrahydrochromen-4-one
|
|
SMILES |
C/C=C/C1=CC(=O)C2=C(O1)C[C@H](C[C@H]2O)O
|
|
InChI |
InChI=1S/C12H14O4/c1-2-3-8-6-10(15)12-9(14)4-7(13)5-11(12)16-8/h2-3,6-7,9,13-14H,4-5H2,1H3/b3-2+/t7-,9+/m0/s1
|
|
InChIKey |
VDNSDCQYWIADNJ-CZQIOHHCSA-N
|
|
Synonyms |
(5R,7S)-5,7-dihydroxy-2-[(E)-prop-1-en-1-yl]- 5,6,7,8-tetrahydro-4H-chromen-4-one
|
|
CAS | NA | |
PubChem CID | 156582519 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 222.24 | ALogp: | 0.1 |
HBD: | 2 | HBA: | 4 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 66.8 | Aromatic Rings: | 2 |
Heavy Atoms: | 16 | QED Weighted: | 0.754 |
Caco-2 Permeability: | -5.01 | MDCK Permeability: | 0.00001370 |
Pgp-inhibitor: | 0.01 | Pgp-substrate: | 0.995 |
Human Intestinal Absorption (HIA): | 0.027 | 20% Bioavailability (F20%): | 0.016 |
30% Bioavailability (F30%): | 0.975 |
Blood-Brain-Barrier Penetration (BBB): | 0.243 | Plasma Protein Binding (PPB): | 71.76% |
Volume Distribution (VD): | 1.097 | Fu: | 38.20% |
CYP1A2-inhibitor: | 0.126 | CYP1A2-substrate: | 0.562 |
CYP2C19-inhibitor: | 0.027 | CYP2C19-substrate: | 0.803 |
CYP2C9-inhibitor: | 0.011 | CYP2C9-substrate: | 0.748 |
CYP2D6-inhibitor: | 0.002 | CYP2D6-substrate: | 0.656 |
CYP3A4-inhibitor: | 0.005 | CYP3A4-substrate: | 0.229 |
Clearance (CL): | 6.168 | Half-life (T1/2): | 0.666 |
hERG Blockers: | 0.049 | Human Hepatotoxicity (H-HT): | 0.926 |
Drug-inuced Liver Injury (DILI): | 0.58 | AMES Toxicity: | 0.057 |
Rat Oral Acute Toxicity: | 0.221 | Maximum Recommended Daily Dose: | 0.988 |
Skin Sensitization: | 0.739 | Carcinogencity: | 0.912 |
Eye Corrosion: | 0.005 | Eye Irritation: | 0.158 |
Respiratory Toxicity: | 0.812 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC004403 | 0.673 | D0CL9S | 0.200 | ||||
ENC004402 | 0.600 | D03TGJ | 0.195 | ||||
ENC004982 | 0.492 | D0YX4S | 0.192 | ||||
ENC001753 | 0.364 | D0EK1D | 0.190 | ||||
ENC006074 | 0.354 | D0G5CF | 0.189 | ||||
ENC003622 | 0.340 | D05BTM | 0.189 | ||||
ENC001843 | 0.327 | D08SVH | 0.189 | ||||
ENC003662 | 0.325 | D0T2PL | 0.189 | ||||
ENC003615 | 0.286 | D0R2KF | 0.188 | ||||
ENC002384 | 0.279 | D01QUS | 0.187 |